130 related articles for article (PubMed ID: 38340443)
21. NQO1-activated multifunctional theranostic probe for imaging-guided mitochondria-targeted photodynamic therapy and boosting immunogenic cell death.
Cao C; Li J; Zhang X; Zhang X; Gong X; Wang S
Talanta; 2024 May; 272():125786. PubMed ID: 38382303
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of NAD(P)H:quinone oxidoreductase 1 (NQO1) and genomic gain of the NQO1 locus modulates breast cancer cell sensitivity to quinones.
Glorieux C; Sandoval JM; Dejeans N; Ameye G; Poirel HA; Verrax J; Calderon PB
Life Sci; 2016 Jan; 145():57-65. PubMed ID: 26687450
[TBL] [Abstract][Full Text] [Related]
23. A bioluminescent probe for NQO1 overexpressing cancer cell imaging
Luo Y; Wang W; Zeng Y; Wang S; Guo X; Hu R; Yang G
Analyst; 2022 Nov; 147(23):5264-5268. PubMed ID: 36330961
[TBL] [Abstract][Full Text] [Related]
24. Development of a new isogenic cell-xenograft system for evaluation of NAD(P)H:quinone oxidoreductase-directed antitumor quinones: evaluation of the activity of RH1.
Dehn DL; Winski SL; Ross D
Clin Cancer Res; 2004 May; 10(9):3147-55. PubMed ID: 15131056
[TBL] [Abstract][Full Text] [Related]
25. Detection and cellular imaging of human cancer enzyme using a turn-on, wavelength-shiftable, self-immolative profluorophore.
Hettiarachchi SU; Prasai B; McCarley RL
J Am Chem Soc; 2014 May; 136(21):7575-8. PubMed ID: 24813575
[TBL] [Abstract][Full Text] [Related]
26. Application of a Specific and Sensitive NQO1 Turn-On Near-Infrared Fluorescence Probe for Live Cancer Cell and Xenografted Tumor Imaging in Nude Mice.
Srivenugopal KS; Arutla V; Punganuru SR; Khan AEMA
Methods Mol Biol; 2024; 2755():63-74. PubMed ID: 38319569
[TBL] [Abstract][Full Text] [Related]
27. A novel two-photon fluorescent probe with a long Stokes shift and a high signal-to-background ratio for human NAD(P)H:quinone oxidoreductase 1 (hNQO1) detection and imaging in living cells and tissues.
Pan D; Luo F; Liu X; Liu W; Chen W; Liu F; Kuang YQ; Jiang JH
Analyst; 2017 Jul; 142(14):2624-2630. PubMed ID: 28608874
[TBL] [Abstract][Full Text] [Related]
28. An improved cell-permeable fluorogenic substrate as the basis for a highly sensitive test for NAD(P)H quinone oxidoreductase 1 (NQO1) in living cells.
Cuff S; Lewis RD; Chinje E; Jaffar M; Knox R; Weeks I
Free Radic Biol Med; 2018 Feb; 116():141-148. PubMed ID: 29325897
[TBL] [Abstract][Full Text] [Related]
29. NAD(P)H:Quinone Acceptor Oxidoreductase 1 (NQO1) Activatable Salicylamide H
Roy NJ; Save SN; Sharma VK; Abraham B; Kuttanamkuzhi A; Sharma S; Lahiri M; Talukdar P
Chemistry; 2023 Sep; 29(51):e202301412. PubMed ID: 37345998
[TBL] [Abstract][Full Text] [Related]
30. NAD(P)H:quinone oxidoreductase1 (DT-diaphorase) expression in normal and tumor tissues.
Belinsky M; Jaiswal AK
Cancer Metastasis Rev; 1993 Jun; 12(2):103-17. PubMed ID: 8375015
[TBL] [Abstract][Full Text] [Related]
31. Implications of NQO1 in cancer therapy.
Oh ET; Park HJ
BMB Rep; 2015 Nov; 48(11):609-17. PubMed ID: 26424559
[TBL] [Abstract][Full Text] [Related]
32. Evidence from ESI-MS for NQO1-catalyzed reduction of estrogen ortho-quinones.
Gaikwad NW; Rogan EG; Cavalieri EL
Free Radic Biol Med; 2007 Nov; 43(9):1289-98. PubMed ID: 17893042
[TBL] [Abstract][Full Text] [Related]
33. Novel quinolinequinone antitumor agents: structure-metabolism studies with NAD(P)H:quinone oxidoreductase (NQO1).
Fryatt T; Pettersson HI; Gardipee WT; Bray KC; Green SJ; Slawin AM; Beall HD; Moody CJ
Bioorg Med Chem; 2004 Apr; 12(7):1667-87. PubMed ID: 15028260
[TBL] [Abstract][Full Text] [Related]
34. The crystal structure of NAD(P)H quinone oxidoreductase 1 in complex with its potent inhibitor dicoumarol.
Asher G; Dym O; Tsvetkov P; Adler J; Shaul Y
Biochemistry; 2006 May; 45(20):6372-8. PubMed ID: 16700548
[TBL] [Abstract][Full Text] [Related]
35. Relationship between NAD(P)H:quinone oxidoreductase 1 (NQO1) levels in a series of stably transfected cell lines and susceptibility to antitumor quinones.
Winski SL; Swann E; Hargreaves RH; Dehn DL; Butler J; Moody CJ; Ross D
Biochem Pharmacol; 2001 Jun; 61(12):1509-16. PubMed ID: 11377380
[TBL] [Abstract][Full Text] [Related]
36. The human dioxin-inducible NAD(P)H: quinone oxidoreductase cDNA-encoded protein expressed in COS-1 cells is identical to diaphorase 4.
Shaw PM; Reiss A; Adesnik M; Nebert DW; Schembri J; Jaiswal AK
Eur J Biochem; 1991 Jan; 195(1):171-6. PubMed ID: 1899380
[TBL] [Abstract][Full Text] [Related]
37. Tumor-selective, futile redox cycle-induced bystander effects elicited by NQO1 bioactivatable radiosensitizing drugs in triple-negative breast cancers.
Cao L; Li LS; Spruell C; Xiao L; Chakrabarti G; Bey EA; Reinicke KE; Srougi MC; Moore Z; Dong Y; Vo P; Kabbani W; Yang CR; Wang X; Fattah F; Morales JC; Motea EA; Bornmann WG; Yordy JS; Boothman DA
Antioxid Redox Signal; 2014 Jul; 21(2):237-50. PubMed ID: 24512128
[TBL] [Abstract][Full Text] [Related]
38. NAD(P)H:quinone oxidoreductase 1 (NQO1) localizes to the mitotic spindle in human cells.
Siegel D; Kepa JK; Ross D
PLoS One; 2012; 7(9):e44861. PubMed ID: 22984577
[TBL] [Abstract][Full Text] [Related]
39. NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism.
Jamieson D; Wilson K; Pridgeon S; Margetts JP; Edmondson RJ; Leung HY; Knox R; Boddy AV
Clin Cancer Res; 2007 Mar; 13(5):1584-90. PubMed ID: 17332305
[TBL] [Abstract][Full Text] [Related]
40. Nucleotide and deduced amino acid sequence of a human cDNA (NQO2) corresponding to a second member of the NAD(P)H:quinone oxidoreductase gene family. Extensive polymorphism at the NQO2 gene locus on chromosome 6.
Jaiswal AK; Burnett P; Adesnik M; McBride OW
Biochemistry; 1990 Feb; 29(7):1899-906. PubMed ID: 1691923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
